BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 19903582)

  • 1. The epidemiology of travelers' diarrhea in Incirlik, Turkey: a region with a predominance of heat-stabile toxin producing enterotoxigenic Escherichia coli.
    Porter CK; Riddle MS; Tribble DR; Putnam SD; Rockabrand DM; Frenck RW; Rozmajzl P; Kilbane E; Fox A; Ruck R; Lim M; Johnston J; Murphy E; Sanders JW
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):241-7. PubMed ID: 19903582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.
    Meraz IM; Jiang ZD; Ericsson CD; Bourgeois AL; Steffen R; Taylor DN; Hernandez N; DuPont HL
    J Travel Med; 2008; 15(6):412-8. PubMed ID: 19090795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested.
    Galbadage T; Jiang ZD; DuPont HL
    Am J Trop Med Hyg; 2009 Jan; 80(1):20-3. PubMed ID: 19141833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997.
    Jiang ZD; Mathewson JJ; Ericsson CD; Svennerholm AM; Pulido C; DuPont HL
    J Infect Dis; 2000 Feb; 181(2):779-82. PubMed ID: 10669376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico.
    Adachi JA; Ericsson CD; Jiang ZD; DuPont MW; Pallegar SR; DuPont HL
    J Infect Dis; 2002 Jun; 185(11):1681-3. PubMed ID: 12023779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey.
    Sanders JW; Frenck RW; Putnam SD; Riddle MS; Johnston JR; Ulukan S; Rockabrand DM; Monteville MR; Tribble DR
    Clin Infect Dis; 2007 Aug; 45(3):294-301. PubMed ID: 18688944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Travelers' diarrhea.
    Hill DR; Beeching NJ
    Curr Opin Infect Dis; 2010 Oct; 23(5):481-7. PubMed ID: 20683261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterotoxigenic Escherichia coli colonization factor types collected from 1997 to 2001 in US military personnel during operation Bright Star in northern Egypt.
    Rockabrand DM; Shaheen HI; Khalil SB; Peruski LF; Rozmajzl PJ; Savarino SJ; Monteville MR; Frenck RW; Svennerholm AM; Putnam SD; Sanders JW
    Diagn Microbiol Infect Dis; 2006 May; 55(1):9-12. PubMed ID: 16542813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.
    Ericsson CD; DuPont HL; Okhuysen PC; Jiang ZD; DuPont MW
    J Travel Med; 2007; 14(5):312-9. PubMed ID: 17883462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pre-deployment loperamide provision on use and travelers' diarrhea outcomes among U.S. military personnel deployed to Turkey.
    Letizia A; Riddle MS; Tribble D; Mostafa M; Monteville M; Armstrong A; Gutierrez RL
    Travel Med Infect Dis; 2014; 12(4):360-3. PubMed ID: 24485100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Traveler's diarrhea, the most common health problem of travelers].
    Lääveri T; Kantele A; Hakanen A; Mattila L
    Duodecim; 2010; 126(4):403-10. PubMed ID: 20486490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic characterization of enterotoxigenic Escherichia coli isolated from U.S. military personnel participating in Operation Bright Star, Egypt, from 2005 to 2009.
    Nada RA; Armstrong A; Shaheen HI; Nakhla I; Sanders JW; Riddle MS; Young S; Sebeny P
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):272-7. PubMed ID: 23639795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of travelers' diarrhea in Thailand.
    Chongsuvivatwong V; Chariyalertsak S; McNeil E; Aiyarak S; Hutamai S; Dupont HL; Jiang ZD; Kalambaheti T; Tonyong W; Thitiphuree S; Steffen R
    J Travel Med; 2009; 16(3):179-85. PubMed ID: 19538578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children.
    Rivera FP; Ochoa TJ; Maves RC; Bernal M; Medina AM; Meza R; Barletta F; Mercado E; Ecker L; Gil AI; Hall ER; Huicho L; Lanata CF
    J Clin Microbiol; 2010 Sep; 48(9):3198-203. PubMed ID: 20631096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.
    Sack RB; Santosham M; Froehlich JL; Medina C; Orskov F; Orskov I
    Am J Trop Med Hyg; 1984 May; 33(3):460-6. PubMed ID: 6375407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea.
    Lundkvist J; Steffen R; Jönsson B
    J Travel Med; 2009; 16(1):28-34. PubMed ID: 19192125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of enteroaggregative Escherichia coli among food handlers in three areas of Kenya: a possible transmission route of travelers' diarrhea.
    Oundo JO; Kariuki SM; Boga HI; Muli FW; Iijima Y
    J Travel Med; 2008; 15(1):31-8. PubMed ID: 18217867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characteristics of enterotoxigenic Escherichia coli associated with acute diarrhea among Israeli young adults.
    Cohen D; Tobias J; Spungin-Bialik A; Sela T; Kayouf R; Volovik Y; Yavzori M; Ephros M
    Foodborne Pathog Dis; 2010 Oct; 7(10):1159-64. PubMed ID: 20590426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case series study of traveler's diarrhea in U.S. military personnel at Incirlik Air Base, Turkey.
    Porter CK; El Mohammady H; Baqar S; Rockabrand DM; Putnam SD; Tribble DR; Riddle MS; Frenck RW; Rozmajzl P; Kilbane E; Fox A; Ruck R; Lim M; Johnston YJ; Murphy E; Sanders JW
    Clin Vaccine Immunol; 2008 Dec; 15(12):1884-7. PubMed ID: 18845833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.
    Flores J; DuPont HL; Jiang ZD; Belkind-Gerson J; Mohamed JA; Carlin LG; Padda RS; Paredes M; Martinez-Sandoval JF; Villa NA; Okhuysen PC
    J Travel Med; 2008; 15(3):156-61. PubMed ID: 18494692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.